AR HB1907

Creates the "Billing in the Best Interest of Patients Act" as a new subchapter (23-99-1401 et seq.) of Arkansas Code Title 23, Chapter 99.

Allows healthcare providers to determine whether to bill a patient's health insurance payor or pharmacy benefits carrier based on what is in the patient's best interest, particularly for hematology and oncology diagnoses.

Prohibits health insurers from requiring patients to self-administer prescription medications if a healthcare provider determines provider administration is in the patient's best interest, regardless of the medication's formulation or benefit category.

Requires healthcare payors to reimburse prescription medication costs and administration through either medical or pharmacy benefits based on the provider's decision, without imposing additional financial penalties, copayments, coinsurance, or deductibles beyond ordinary plan terms.

Does not apply to risk-based provider organizations under the Medicaid Provider-Led Organized Care Act or individual qualified health insurance plans under the Arkansas Health and Opportunity for Me Act of 2021.

Exempts solid oral dosage medications from these requirements unless they are oral anticancer medications, oral antiemetic medications given with chemotherapy, or carry FDA safety labels requiring supervised administration.